CYP2B6 and major depressive disorder: Furthermore, bupropion is metabolized by CYP2B6 and is prescribed to depression patients who have other psychiatric comorbidities such as attention deficit hyperactivity or substance use disorders, which may contribute to a higher baseline risk of adverse events [33].